Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Hypertension: HELP
Articles from Unspecified
Based on 2,423 articles published since 2008
||||

These are the 2423 published articles about Hypertension that originated from Unspecified during 2008-2019.
 
+ Citations + Abstracts
Pages: 1 · 2 · 3 · 4 · 5 · 6 · 7 · 8 · 9 · 10 · 11 · 12 · 13 · 14 · 15 · 16 · 17 · 18 · 19 · 20
1 Guideline [2018 ESC/ESH Guidelines for the Management of Arterial Hypertension: What's New with Regard to Our Older People?] 2018

Hoffmann, Ute / Thrun, Jan-Marc. ·Klinik für Allgemeine Innere Medizin und Geriatrie, Angiologie, Diabetologie, Endokrinologie, Nephrologie, Krankenhaus Barmherzige Brüder Regensburg. ·Dtsch Med Wochenschr · Pubmed #30508852.

ABSTRACT: In the "2018 ESC/ESH Guidelines for the management of arterial hypertension" there are new blood pressure (BP) recommendations with regard to older patients based on randomized controlled trials and well-conducted meta-analyses performed during the last years.It is recommended to base the diagnosis of hypertension on repeated office BP measurements under standardized conditions and in older people in out-of-office BP measurement with ABPM and/or HBPM if logistically and economically feasible. Furthermore lying and standing BP measurements should also be considered in subsequent visits in older people to exclude orthostatic hypotension.Older people should measure their BP in upper arms by validated devices with a well readable display.In the new guidelines more attention is directed on frailty, concomitant treatments and independence influencing the likely tolerability of BP-lowering medications. In fit older patients, it is now recommended that systolic BP should be targeted to a BP range of 130 - 139 mmHg, if tolerated.Lifestyle changes are also recommended in elder patients. Preferred combination therapies are a RAS blocker with a CCB or thiazid diuretic, preferably in a "single pill". When combination therapy is used, this should be initiated at the lowest available doses in elder people.

2 Guideline Canadian stroke best practice recommendations: Secondary prevention of stroke, sixth edition practice guidelines, update 2017. 2018

Wein, Theodore / Lindsay, M Patrice / Côté, Robert / Foley, Norine / Berlingieri, Joseph / Bhogal, Sanjit / Bourgoin, Aline / Buck, Brian H / Cox, Jafna / Davidson, Dion / Dowlatshahi, Dar / Douketis, Jim / Falconer, John / Field, Thalia / Gioia, Laura / Gubitz, Gord / Habert, Jeffrey / Jaspers, Sharon / Lum, Cheemun / McNamara Morse, Dana / Pageau, Paul / Rafay, Mubeen / Rodgerson, Amanda / Semchuk, Bill / Sharma, Mukul / Shoamanesh, Ashkan / Tamayo, Arturo / Smitko, Elisabeth / Gladstone, David J / Anonymous801124. ·1 McGill University, Canada. · 2 Montreal General Hospital, Canada. · 3 282184 Heart and Stroke Foundation , Canada. · 4 Western University, Canada. · 6 workHORSE Consulting, London. · 5 JBN Medical Diagnostic Services, Canada. · 7 Champlain Regional Stroke Network, Canada. · 8 Division of Neurology, Department of Medicine, University of Alberta, Canada. · 9 Department of Medicine, Dalhousie University, Canada. · 10 41694 Valley Regional Hospital , Nova Scotia, Canada. · 11 Stroke Program, Ottawa Civic Hospital, Canada. · 12 Divisions of General Internal Medicine, Hematology and Thromboembolism, 152997 McMaster University Department of Medicine , Canada. · 13 Thrombosis Canada, Canada. · 14 59140 Kelowna General Hospital , Canada. · 15 Faculty of Medicine, University of British Columbia, Canada. · 16 Department of Neurosciences, CHUM-Centre Hospitalier de l'Université de Montréal, Hôpital Notre Dame, Canada. · 17 Queen Elizabeth II Stroke Program, Nova Scotia, Canada. · 18 Department of Family and Community Medicine, University of Toronto, Canada. · 19 Thunder Bay Regional Health Sciences Centre, Canada. · 20 Department of Emergency Medicine, The 6363 University of Ottawa , Canada. · 21 Winnipeg Children's Hospital, Canada. · 22 423136 University of Manitoba , Canada. · 23 Regina Qu'Appellle Health Region, Canada. · 24 Population Health Research Institute, McMaster University, Canada. · 25 Brandon Regional Hospital, Manitoba, Canada. · 26 Sunnybrook Health Sciences Centre, Hurvitz Brain Sciences Program, Sunnybrook Research Institute, Toronto, Canada. · 27 University of Toronto Department of Medicine, Toronto, Canada. ·Int J Stroke · Pubmed #29171361.

ABSTRACT: The 2017 update of The Canadian Stroke Best Practice Recommendations for the Secondary Prevention of Stroke is a collection of current evidence-based recommendations intended for use by clinicians across a wide range of settings. The goal is to provide guidance for the prevention of ischemic stroke recurrence through the identification and management of modifiable vascular risk factors. Recommendations include those related to diagnostic testing, diet and lifestyle, smoking, hypertension, hyperlipidemia, diabetes, antiplatelet and anticoagulant therapies, carotid artery disease, atrial fibrillation, and other cardiac conditions. Notable changes in this sixth edition include the development of core elements for delivering secondary stroke prevention services, the addition of a section on cervical artery dissection, new recommendations regarding the management of patent foramen ovale, and the removal of the recommendations on management of sleep apnea. The Canadian Stroke Best Practice Recommendations include a range of supporting materials such as implementation resources to facilitate the adoption of evidence to practice, and related performance measures to enable monitoring of uptake and effectiveness of the recommendations. The guidelines further emphasize the need for a systems approach to stroke care, involving an interprofessional team, with access to specialists regardless of patient location, and the need to overcome geographic barriers to ensure equity in access within a universal health care system.

3 Guideline Hypertension and cardiac arrhythmias: a consensus document from the European Heart Rhythm Association (EHRA) and ESC Council on Hypertension, endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS) and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE). 2017

Lip, Gregory Y H / Coca, Antonio / Kahan, Thomas / Boriani, Giuseppe / Manolis, Antonis S / Olsen, Michael Hecht / Oto, Ali / Potpara, Tatjana S / Steffel, Jan / Marín, Francisco / de Oliveira Figueiredo, Márcio Jansen / de Simone, Giovanni / Tzou, Wendy S / Chiang, Chern-En / Williams, Bryan / Anonymous4830918 / Dan, Gheorghe-Andrei / Gorenek, Bulent / Fauchier, Laurent / Savelieva, Irina / Hatala, Robert / van Gelder, Isabelle / Brguljan-Hitij, Jana / Erdine, Serap / Lovic, Dragan / Kim, Young-Hoon / Salinas-Arce, Jorge / Field, Michael. ·Institute of Cardiovascular Sciences, University of Birmingham, UK. · Aalborg Thrombosis Research Unit, Department of Clinical Medicine, Aalborg University, Aalborg, Denmark. · Hypertension and Vascular Risk Unit, Department of Internal Medicine, Hospital Clínic (IDIBAPS), University of Barcelona, Barcelona, Spain. · Karolinska Institutet Department of Clinical Sciences, Danderyd Hospital, Stockholm, Sweden. · Department of Cardiology, Danderyd University Hospital Corp, Stockholm, Sweden. · Cardiology Department, University of Modena and Reggio Emilia, Policlinico di Modena, Modena, Italy. · Third Department of Cardiology, Athens University School of Medicine, Athens, Greece. · Department of Internal Medicine, Holbaek Hospital and Centre for Individualized Medicine in Arterial Diseases (CIMA), Odense University Hospital, University of Southern Denmark, Denmark. · Department of Cardiology, Memorial Ankara Hospital, Heart and Health Foundation of Turkey, Ankara, Turkey. · School of Medicine, Cardiology Clinic, Clinical Centre of Serbia, Belgrade University, Belgrade, Serbia. · Electrophysiology and Cardiac Devices, Department of Cardiology, University Heart Center Zurich; Zurich, Switzerland. · Department of Cardiology, Hospital Universitario Virgen de la Arrixaca, IMIB-Arrixaca, University of Murcia, Murcia, Spain. · Cardiology Department, Medicine School, State University of Campinas, Sao Paulo, Brazil. · Department of Translational Medical Sciences, Federico II University Hospital, via S. Pansini 5, bld # 1, Napoli 80131, Italy. · Cardiac Electrophysiology, Division of Cardiology, University of Colorado School of Medicine, Aurora, CO, USA. · Division of Cardiology, Taipei Veterans General Hospital, National Yang-Ming University, Taipei, Taiwan. · Institute of Cardiovascular Science, University College London, UK. · Colentina University Hospital, Medicine Faculty, University of Medicine "Carol Davila"-Bucharest Romania. · Eskisehir Osmangazi University, Eskisehir, Turkey. · Centre Hospitalier Universitaire Trousseau, Tours, France. · St George's University Of London, London, UK. · National Cardiovascular Institute, NUSCH, Bratislava, Slovak Republic. · University of Groningen, University Medical Center Groningen, Groningen, The Netherlands. · University Medical Centre, Hypertension Department, Hospital Dr. Peter Drzaja, Ljubljana, Slovenia. · Istanbul University Cerrahpasa Medical School, Head of Hypertension Department, Istanbul, Turkey. · Clinic for internal disease Intermedica, Cardiology department-Hypertension centere, Serbia. · Korea University Medical Center, Seoul, Korea. · Clínica Delgado, Miraflores, Pérou. · University of Wisconsin, Clinical Science Center, Madison, USA. ·Europace · Pubmed #28881872.

ABSTRACT: Hypertension is a common cardiovascular risk factor leading to heart failure (HF), coronary artery disease, stroke, peripheral artery disease and chronic renal insufficiency. Hypertensive heart disease can manifest as many cardiac arrhythmias, most commonly being atrial fibrillation (AF). Both supraventricular and ventricular arrhythmias may occur in hypertensive patients, especially in those with left ventricular hypertrophy (LVH) or HF. Also, some of the antihypertensive drugs commonly used to reduce blood pressure, such as thiazide diuretics, may result in electrolyte abnormalities (e.g. hypokalaemia, hypomagnesemia), further contributing to arrhythmias, whereas effective control of blood pressure may prevent the development of the arrhythmias such as AF. In recognizing this close relationship between hypertension and arrhythmias, the European Heart Rhythm Association (EHRA) and the European Society of Cardiology (ESC) Council on Hypertension convened a Task Force, with representation from the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE), with the remit to comprehensively review the available evidence to publish a joint consensus document on hypertension and cardiac arrhythmias, and to provide up-to-date consensus recommendations for use in clinical practice. The ultimate judgment regarding care of a particular patient must be made by the healthcare provider and the patient in light of all of the circumstances presented by that patient.

4 Guideline Clinical Practice Guideline for Screening and Management of High Blood Pressure in Children and Adolescents. 2017

Flynn, Joseph T / Kaelber, David C / Baker-Smith, Carissa M / Blowey, Douglas / Carroll, Aaron E / Daniels, Stephen R / de Ferranti, Sarah D / Dionne, Janis M / Falkner, Bonita / Flinn, Susan K / Gidding, Samuel S / Goodwin, Celeste / Leu, Michael G / Powers, Makia E / Rea, Corinna / Samuels, Joshua / Simasek, Madeline / Thaker, Vidhu V / Urbina, Elaine M / Anonymous5820916. ·Dr. Robert O. Hickman Endowed Chair in Pediatric Nephrology, Division of Nephrology, Department of Pediatrics, University of Washington and Seattle Children's Hospital, Seattle, Washington; joseph.flynn@seattlechildrens.org. · Departments of Pediatrics, Internal Medicine, Population and Quantitative Health Sciences, Center for Clinical Informatics Research and Education, Case Western Reserve University and MetroHealth System, Cleveland, Ohio. · Division of Pediatric Cardiology, School of Medicine, University of Maryland, Baltimore, Maryland. · Children's Mercy Hospital, University of Missouri-Kansas City and Children's Mercy Integrated Care Solutions, Kansas City, Missouri. · Department of Pediatrics, School of Medicine, Indiana University, Bloomington, Indiana. · Department of Pediatrics, School of Medicine, University of Colorado-Denver and Pediatrician in Chief, Children's Hospital Colorado, Aurora, Colorado. · Director, Preventive Cardiology Clinic, Boston Children's Hospital, Department of Pediatrics, Harvard Medical School, Boston, Massachusetts. · Division of Nephrology, Department of Pediatrics, University of British Columbia and British Columbia Children's Hospital, Vancouver, British Columbia, Canada. · Departments of Medicine and Pediatrics, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania. · Consultant, American Academy of Pediatrics, Washington, District of Columbia. · Cardiology Division Head, Nemours Cardiac Center, Alfred I. duPont Hospital for Children, Wilmington, Delaware. · National Pediatric Blood Pressure Awareness Foundation, Prairieville, Louisiana. · Departments of Pediatrics and Biomedical Informatics and Medical Education, University of Washington, University of Washington Medicine and Information Technology Services, and Seattle Children's Hospital, Seattle, Washington. · Department of Pediatrics, School of Medicine, Morehouse College, Atlanta, Georgia. · Associate Director, General Academic Pediatric Fellowship, Staff Physician, Boston's Children's Hospital Primary Care at Longwood, Instructor, Harvard Medical School, Boston, Massachusetts. · Departments of Pediatrics and Internal Medicine, McGovern Medical School, University of Texas, Houston, Texas. · Pediatric Education, University of Pittsburgh Medical Center Shadyside Family Medicine Residency, Clinical Associate Professor of Pediatrics, Children's Hospital of Pittsburgh of University of Pittsburgh Medical Center, and School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania. · Division of Molecular Genetics, Department of Pediatrics, Columbia University Medical Center, New York, New York; and. · Preventive Cardiology, Cincinnati Children's Hospital Medical Center, Department of Pediatrics, University of Cincinnati, Cincinnati, Ohio. ·Pediatrics · Pubmed #28827377.

ABSTRACT: These pediatric hypertension guidelines are an update to the 2004 "Fourth Report on the Diagnosis, Evaluation, and Treatment of High Blood Pressure in Children and Adolescents." Significant changes in these guidelines include (1) the replacement of the term "prehypertension" with the term "elevated blood pressure," (2) new normative pediatric blood pressure (BP) tables based on normal-weight children, (3) a simplified screening table for identifying BPs needing further evaluation, (4) a simplified BP classification in adolescents ≥13 years of age that aligns with the forthcoming American Heart Association and American College of Cardiology adult BP guidelines, (5) a more limited recommendation to perform screening BP measurements only at preventive care visits, (6) streamlined recommendations on the initial evaluation and management of abnormal BPs, (7) an expanded role for ambulatory BP monitoring in the diagnosis and management of pediatric hypertension, and (8) revised recommendations on when to perform echocardiography in the evaluation of newly diagnosed hypertensive pediatric patients (generally only before medication initiation), along with a revised definition of left ventricular hypertrophy. These guidelines include 30 Key Action Statements and 27 additional recommendations derived from a comprehensive review of almost 15 000 published articles between January 2004 and July 2016. Each Key Action Statement includes level of evidence, benefit-harm relationship, and strength of recommendation. This clinical practice guideline, endorsed by the American Heart Association, is intended to foster a patient- and family-centered approach to care, reduce unnecessary and costly medical interventions, improve patient diagnoses and outcomes, support implementation, and provide direction for future research.

5 Guideline ISFM Consensus Guidelines on the Diagnosis and Management of Hypertension in Cats. 2017

Taylor, Samantha S / Sparkes, Andrew H / Briscoe, Katherine / Carter, Jenny / Sala, Salva Cervantes / Jepson, Rosanne E / Reynolds, Brice S / Scansen, Brian A. ·1 International Cat Care/ISFM, Tisbury, Wiltshire SP3 6LD, UK. · 2 Animal Referral Hospital, 250 Parramatta Road, Homebush, Sydney, NSW 2140, Australia. · 3 PO Box 128209, Remuera, Auckland 1541, New Zealand. · 4 Clínica Felina Barcelona, C/Marqués de Campo Sagrado 12, Barcelona, Spain. · 5 Clinical Sciences and Services, Royal Veterinary College, Hawkshead Lane, Hatfield, Hertfordshire, AL9 7TA, UK. · 6 Université de Toulouse, ENVT, Toulouse, France. · 7 Associate Professor, Department of Clinical Sciences, Colorado State University, Campus Delivery 1678, Fort Collins, CO 80523, USA. ·J Feline Med Surg · Pubmed #28245741.

ABSTRACT: Practical relevance: Feline hypertension is a common disease in older cats that is frequently diagnosed in association with other diseases such as chronic kidney disease and hyperthyroidism (so-called secondary hypertension), although some cases of apparent primary hypertension are also reported. The clinical consequences of hypertension can be severe, related to 'target organ damage' (eye, heart and vasculature, brain and kidneys), and early diagnosis followed by appropriate therapeutic management should help reduce the morbidity associated with this condition. Clinical challenges: Despite being a common disease, routine blood pressure (BP) monitoring is generally performed infrequently, probably leading to underdiagnosis of feline hypertension in clinical practice. There is a need to: (i) ensure BP is measured as accurately as possible with a reproducible technique; (ii) identify and monitor patients at risk of developing hypertension; (iii) establish appropriate criteria for therapeutic intervention; and (iv) establish appropriate therapeutic targets. Based on current data, amlodipine besylate is the treatment of choice to manage feline hypertension and is effective in the majority of cats, but the dose needed to successfully manage hypertension varies between individuals. Some cats require long-term adjuvant therapy and, occasionally, additional therapy is necessary for emergency management of hypertensive crises. Evidence base: These Guidelines from the International Society of Feline Medicine (ISFM) are based on a comprehensive review of the currently available literature, and are aimed at providing practical recommendations to address the challenges of feline hypertension for veterinarians. There are many areas where more data is required which, in the future, will serve to confirm or modify some of the recommendations in these Guidelines.

6 Guideline Guideline for the diagnosis and management of hypertension in adults - 2016. 2016

Gabb, Genevieve M / Mangoni, Arduino A / Anderson, Craig S / Cowley, Diane / Dowden, John S / Golledge, Jonathan / Hankey, Graeme J / Howes, Faline S / Leckie, Les / Perkovic, Vlado / Schlaich, Markus / Zwar, Nicholas A / Medley, Tanya L / Arnolda, Leonard. ·Royal Adelaide Hospital, Adelaide, SA genevieve.gabb@sa.gov.au. · Flinders Medical Centre, Flinders University, Adelaide, SA. · The George Institute for Global Health, Sydney, NSW. · Princess Alexandra Hospital, Brisbane, QLD. · Australian Prescriber, Canberra, ACT. · Queensland Research Centre for Peripheral Vascular Disease, James Cook University, Townsville, QLD. · University of Western Australia, Perth, WA. · Royal Adelaide Hospital, Adelaide, SA. ·Med J Aust · Pubmed #27456450.

ABSTRACT: The National Heart Foundation of Australia has updated the Guide to management of hypertension 2008: assessing and managing raised blood pressure in adults (updated December 2010). Main recommendations For patients at low absolute cardiovascular disease risk with persistent blood pressure (BP) ≥ 160/100 mmHg, start antihypertensive therapy. The decision to treat at lower BP levels should consider absolute cardiovascular disease risk and/or evidence of end-organ damage, together with accurate BP assessment. For patients at moderate absolute cardiovascular disease risk with persistent systolic BP ≥ 140 mmHg and/or diastolic BP ≥ 90 mmHg, start antihypertensive therapy. Treat patients with uncomplicated hypertension to a target BP of < 140/90 mmHg or lower if tolerated. Changes in management as a result of the guideline Ambulatory and/or home BP monitoring should be offered if clinic BP is ≥ 140/90 mmHg, as out-of-clinic BP is a stronger predictor of outcome. In selected high cardiovascular risk populations, aiming for a target of < 120 mmHg systolic can improve cardiovascular outcomes. If targeting < 120 mmHg, close follow-up is recommended to identify treatment-related adverse effects including hypotension, syncope, electrolyte abnormalities and acute kidney injury. Why the changes have been made A 2015 meta-analysis of patients with uncomplicated mild hypertension (systolic BP range, 140-169 mmHg) demonstrated that BP-lowering therapy is beneficial (reduced stroke, cardiovascular death and all-cause mortality). A 2015 trial comparing lower with higher blood pressure targets in selected high cardiovascular risk populations found improved cardiovascular outcomes and reduced mortality, with an increase in some treatment-related adverse events.

7 Guideline 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts)Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). 2016

Piepoli, Massimo F / Hoes, Arno W / Agewall, Stefan / Albus, Christian / Brotons, Carlos / Catapano, Alberico L / Cooney, Marie-Therese / Corrà, Ugo / Cosyns, Bernard / Deaton, Christi / Graham, Ian / Hall, Michael Stephen / Hobbs, F D Richard / Løchen, Maja-Lisa / Löllgen, Herbert / Marques-Vidal, Pedro / Perk, Joep / Prescott, Eva / Redon, Josep / Richter, Dimitrios J / Sattar, Naveed / Smulders, Yvo / Tiberi, Monica / van der Worp, H Bart / van Dis, Ineke / Verschuren, W M Monique / Binno, Simone / Anonymous501013. ·Societie: European Society of Cardiology (ESC). · International Society of Behavioural Medicine (ISBM). · WONCA Europe. · Societie: European Atherosclerosis Society (EAS). · International Diabetes Federation European Region (IDF Europe). · International Federation of Sport Medicine (FIMS). · Societie: European Society of Hypertension (ESH). · Societie: European Association for the Study of Diabetes (EASD). · Societie: European Stroke Organisation (ESO). · Societie: European Heart Network (EHN). ·Eur Heart J · Pubmed #27222591.

ABSTRACT: -- No abstract --

8 Guideline The measurement of adult blood pressure and management of hypertension before elective surgery: Joint Guidelines from the Association of Anaesthetists of Great Britain and Ireland and the British Hypertension Society. 2016

Hartle, A / McCormack, T / Carlisle, J / Anderson, S / Pichel, A / Beckett, N / Woodcock, T / Heagerty, A. ·Department of Anaesthesia and Intensive Care, St Mary's Hospital, London, UK. · Whitby Group Practice/British Hypertension Society, Spring Vale Medical Centre, Whitby, UK. · Departments of Anaesthesia, Peri-operative Medicine and Intensive Care, Torbay Hospital, Torquay, UK. · Institute of Cardiovascular Sciences/British Hypertension Society, University of Manchester, Manchester, UK. · Department of Anaesthesia, Manchester Royal Infirmary, Manchester, UK. · Department of Ageing and Health, Guys' and St Thomas' Hospital/British Hypertension Society, London, UK. · Hampshire, UK. · Department of Medicine, University of Manchester/British Hypertension Society, Manchester, UK. ·Anaesthesia · Pubmed #26776052.

ABSTRACT: This guideline aims to ensure that patients admitted to hospital for elective surgery are known to have blood pressures below 160 mmHg systolic and 100 mmHg diastolic in primary care. The objective for primary care is to fulfil this criterion before referral to secondary care for elective surgery. The objective for secondary care is to avoid spurious hypertensive measurements. Secondary care should not attempt to diagnose hypertension in patients who are normotensive in primary care. Patients who present to pre-operative assessment clinics without documented primary care blood pressures should proceed to elective surgery if clinic blood pressures are below 180 mmHg systolic and 110 mmHg diastolic.

9 Guideline Joint UK societies' 2014 consensus statement on renal denervation for resistant hypertension. 2015

Lobo, Melvin D / de Belder, Mark A / Cleveland, Trevor / Collier, David / Dasgupta, Indranil / Deanfield, John / Kapil, Vikas / Knight, Charles / Matson, Matthew / Moss, Jonathan / Paton, Julian F R / Poulter, Neil / Simpson, Iain / Williams, Bryan / Caulfield, Mark J / Anonymous61006 / Anonymous71006 / Anonymous81006 / Anonymous91006. ·On behalf of the British Hypertension Society Barts NIHR Cardiovascular Biomedical Research Unit, William Harvey Research Institute, Queen Mary University of London, London, UK Department of Cardiovascular Medicine, Barts Health NHS Trust, London, UK. · The British Cardiovascular Society The British Cardiovascular Intervention Society Cardiothoracic Division, The James Cook University Hospital, Middlesbrough, UK. · The British Society for Interventional Radiology Sheffield Vascular Institute, Sheffield Teaching Hospitals NHSFT, Northern General Hospital, Sheffield, UK. · On behalf of the British Hypertension Society Barts NIHR Cardiovascular Biomedical Research Unit, William Harvey Research Institute, Queen Mary University of London, London, UK. · The Renal Association Department of Renal Medicine, Birmingham Heartlands Hospital, Birmingham, UK. · Cardiothoracic Division, The James Cook University Hospital, Middlesbrough, UK The National Institute for Cardiovascular Outcomes Research, University College London, London, UK. · Department of Cardiovascular Medicine, Barts Health NHS Trust, London, UK The British Cardiovascular Society. · The British Society for Interventional Radiology Barts NIHR Cardiovascular Biomedical Research Unit, William Harvey Research Institute, Queen Mary University of London, London, UK. · The British Society for Interventional Radiology Interventional Radiology Unit, Gartnavel General Hospital, Glasgow, UK. · On behalf of the British Hypertension Society School of Physiology & Pharmacology, Bristol Cardiovascular Medical Sciences Building, University of Bristol, Bristol, UK. · On behalf of the British Hypertension Society International Centre for Circulatory Health, Imperial College, London, UK. · The British Cardiovascular Society Wessex Regional Cardiac Unit, University Hospital Southampton, UK. · On behalf of the British Hypertension Society Institute of Cardiovascular Sciences, University College London, London, UK. ·Heart · Pubmed #25431461.

ABSTRACT: Resistant hypertension continues to pose a major challenge to clinicians worldwide and has serious implications for patients who are at increased risk of cardiovascular morbidity and mortality with this diagnosis. Pharmacological therapy for resistant hypertension follows guidelines-based regimens although there is surprisingly scant evidence for beneficial outcomes using additional drug treatment after three antihypertensives have failed to achieve target blood pressure. Recently there has been considerable interest in the use of endoluminal renal denervation as an interventional technique to achieve renal nerve ablation and lower blood pressure. Although initial clinical trials of renal denervation in patients with resistant hypertension demonstrated encouraging office blood pressure reduction, a large randomised control trial (Symplicity HTN-3) with a sham-control limb, failed to meet its primary efficacy end point. The trial however was subject to a number of flaws which must be taken into consideration in interpreting the final results. Moreover a substantial body of evidence from non-randomised smaller trials does suggest that renal denervation may have an important role in the management of hypertension and other disease states characterised by overactivation of the sympathetic nervous system. The Joint UK Societies does not recommend the use of renal denervation for treatment of resistant hypertension in routine clinical practice but remains committed to supporting research activity in this field. A number of research strategies are identified and much that can be improved upon to ensure better design and conduct of future randomised studies.

10 Guideline Early identification and management of chronic kidney disease in adults: summary of updated NICE guidance. 2014

Carville, Serena / Wonderling, David / Stevens, Paul / Anonymous2730801. ·National Clinical Guideline Centre, Royal College of Physicians, London NW1 4LE, UK. · East Kent Hospitals University NHS Foundation Trust, Canterbury CT1 3NG, UK pstevens@nhs.net. ·BMJ · Pubmed #25059691.

ABSTRACT: -- No abstract --

11 Guideline [Cardiovascular preventive recommendations]. 2014

Maiques Galán, Antonio / Brotons Cuixart, Carlos / Villar Álvarez, Fernando / Martín Rioboó, Enrique / Banegas Banegas, José Ramón / Navarro Pérez, Jorge / Alemán Sánchez, José Juan / Lobos-Bejarano, José María / Ortega Sánchez-Pinilla, Ricardo / Orozco-Beltrán, Domingo / Gil Guillén, Vicente / Anonymous540798. ·Grupo de Prevención Cardiovascular del PAPPS. ·Aten Primaria · Pubmed #24950627.

ABSTRACT: -- No abstract --

12 Guideline European Society of Hypertension practice guidelines for ambulatory blood pressure monitoring. 2014

Parati, Gianfranco / Stergiou, George / O'Brien, Eoin / Asmar, Roland / Beilin, Lawrence / Bilo, Grzegorz / Clement, Denis / de la Sierra, Alejandro / de Leeuw, Peter / Dolan, Eamon / Fagard, Robert / Graves, John / Head, Geoffrey A / Imai, Yutaka / Kario, Kazuomi / Lurbe, Empar / Mallion, Jean-Michel / Mancia, Giuseppe / Mengden, Thomas / Myers, Martin / Ogedegbe, Gbenga / Ohkubo, Takayoshi / Omboni, Stefano / Palatini, Paolo / Redon, Josep / Ruilope, Luis M / Shennan, Andrew / Staessen, Jan A / vanMontfrans, Gert / Verdecchia, Paolo / Waeber, Bernard / Wang, Jiguang / Zanchetti, Alberto / Zhang, Yuqing / Anonymous350796. ·aAuthor affiliations are listed on the Journal website, http://links.lww.com/HJH/A366 bAuthor affiliations are listed on the Journal website, http://links.lww.com/HJH/A366 cAuthor affiliations are listed on the Journal website, http://links.lww.com/HJH/A366 dAuthor affiliations are listed on the Journal website, http://links.lww.com/HJH/A366 eAuthor affiliations are listed on the Journal website, http://links.lww.com/HJH/A366 fAuthor affiliations are listed on the Journal website, http://links.lww.com/HJH/A366 gAuthor affiliations are listed on the Journal website, http://links.lww.com/HJH/A366 hAuthor affiliations are listed on the Journal website, http://links.lww.com/HJH/A366 iAuthor affiliations are listed on the Journal website, http://links.lww.com/HJH/A366 jAuthor affiliations are listed on the Journal website, http://links.lww.com/HJH/A366 kAuthor affiliations are listed on the Journal website, http://links.lww.com/HJH/A366 lAuthor affiliations are listed on the Journal website, http://links.lww.com/HJH/A366 mAuthor affiliations are listed on the Journal website, http://links.lww.com/HJH/A366 nAuthor affiliations are listed on the Journal website, http://links.lww.com/HJH/A366 oAuthor affiliations are listed on the Journal website, http://links.lww.com/HJH/A366 pAuthor affiliations are listed on the Journal website, http://links.lww.com/HJH/A366 qAuthor affiliations are listed on the Journal website, http://links.lww.com/HJH/A366 rAuthor affiliations are listed on the Journal website, http://links.lww.com/HJH/A366 sAuthor affiliations are listed on the Journal website, http://links.lww.com/HJH/A366 tAuthor affiliations are listed on the Journal website, http://links.lww.com/HJH/A366 uAuthor affiliations are listed on the Journal website, http://links.lww.com/HJH/A366 vAuthor affiliations are listed on the Journal website, http://links.lww.com/HJH/A366 wAuthor affiliations are listed on the Journal website, http://links.lww.com/HJH/A366 xAuthor affiliations a ·J Hypertens · Pubmed #24886823.

ABSTRACT: Given the increasing use of ambulatory blood pressure monitoring (ABPM) in both clinical practice and hypertension research, a group of scientists, participating in the European Society of Hypertension Working Group on blood pressure monitoring and cardiovascular variability, in year 2013 published a comprehensive position paper dealing with all aspects of the technique, based on the available scientific evidence for ABPM. The present work represents an updated schematic summary of the most important aspects related to the use of ABPM in daily practice, and is aimed at providing recommendations for proper use of this technique in a clinical setting by both specialists and practicing physicians. The present article details the requirements and the methodological issues to be addressed for using ABPM in clinical practice, The clinical indications for ABPM suggested by the available studies, among which white-coat phenomena, masked hypertension, and nocturnal hypertension, are outlined in detail, and the place of home measurement of blood pressure in relation to ABPM is discussed. The role of ABPM in pharmacological, epidemiological, and clinical research is also briefly mentioned. Finally, the implementation of ABPM in practice is considered in relation to the situation of different countries with regard to the reimbursement and the availability of ABPM in primary care practices, hospital clinics, and pharmacies.

13 Guideline [Latin American consensus on hypertension in patients with diabetes type 2 and metabolic syndrome]. 2014

López-Jaramillo, Patricio / Sánchez, Ramiro A / Diaz, Margarita / Cobos, Leonardo / Bryce, Alfonso / Parra-Carrillo, Jose Z / Lizcano, Fernando / Lanas, Fernando / Sinay, Isaac / Sierra, Iván D / Peñaherrera, Ernesto / Bendersky, Mario / Schmid, Helena / Botero, Rodrigo / Urina, Manuel / Lara, Joffre / Foss, Milton C / Márquez, Gustavo / Harrap, Stephen / Ramírez, Agustín J / Zanchetti, Alberto / Anonymous2580795. ·Fundación Oftalmológica de Santander FOSCAL, Universidad de Santander UDES, Bucaramanga, Colômbia. · Unidad de Metabolismo e Hipertensión Arterial, Hospital Universitario, Fundación Favaloro, Buenos Aires, Argentina. · Clínica Platinum, Montevideo, Uruguai. · Colegio Panamericano del Endotelio, Santiago, Chile. · Clínica de Golf, Lima, Peru. · Universidad de Guadalajara, Guadalajara, México. · Asociación Colombiana de Endocrinología, Universidad de la Sabana, Bogotá, Colômbia. · Universidad de la Frontera, Temuco, Chile. · Instituto Cardiológico de Buenos Aires, Buenos aires, Argentina. · Asociación Latinoamericana de Diabetes, Bogotá, Colômbia. · Hospital Luis Vernaza, Guayaquil, Equador. · Universidad de Córdova, Córdova, Argentina. · Universidade Federal do Rio Grande do Sul, Porto Alegre, Brasil. · Centro Médico, Medellín, Colômbia. · Sociedad Colombiana de Cardiología, Bogotá, Colômbia. · Sociedad Ecuatoriana de Aterosclerosis, Guayaquil, Equador. · Universidade de São Paulo, Ribeirão Preto, Brasil. · Federación Diabetológica Colombiana, Corozal, Colômbia. · University of Melbourne, Melbourne, Australia. · Instituto Auxológico Italiano, Milão, Itália. ·Arq Bras Endocrinol Metabol · Pubmed #24863082.

ABSTRACT: The present document has been prepared by a group of experts, members of cardiology, endocrinology, internal medicine, nephrology and diabetes societies of Latin American countries, to serve as a guide to physicians taking care of patients with diabetes, hypertension and comorbidities or complications of both conditions. Although the concept of metabolic syndrome is currently disputed, the higher prevalence in Latin America of that cluster of metabolic alterations has suggested that metabolic syndrome is a useful nosography entity in the context of Latin American medicine. Therefore, in the present document, particular attention is paid to this syndrome in order to alert physicians on a particular high-risk population, usually underestimated and undertreated. These recommendations result from presentations and debates by discussion panels during a 2-day conference held in Bucaramanga, in October 2012, and all the participants have approved the final conclusions. The authors acknowledge that the publication and diffusion of guidelines do not suffice to achieve the recommended changes in diagnostic or therapeutic strategies, and plan suitable interventions overcoming knowledge, attitude and behavioural barriers, preventing both physicians and patients from effectively adhering to guideline recommendations.

14 Guideline [Management of arterial hypertension in adults: 2013 guidelines of the French Society of Arterial Hypertension]. 2013

Blacher, J / Halimi, J-M / Hanon, O / Mourad, J-J / Pathak, A / Schnebert, B / Girerd, X / Anonymous2990760. ·contact.sfhta@cardio-sfc.org ·Ann Cardiol Angeiol (Paris) · Pubmed #23743000.

ABSTRACT: BEFORE STARTING TREATMENT: 1. Confirm the diagnosis, with blood pressure measurements outside the doctor's office. 2. Implement lifestyle measures. 3. Conduct an initial assessment. 4. Arrange a dedicated information and hypertension announcement consultation. INITIAL TREATMENT PLAN (FIRST 6 MONTHS): 5. MAIN OBJECTIVE: control of blood pressure in the first 6 months (SBP: 130-139 and DBP<90 mmHg). 6. Favour the five classes of antihypertensive agents that have demonstrated prevention of cardiovascular complications in hypertensive patients. 7. Individualized choice of the first antihypertensive treatment, taking into account persistence. 8. Promote the use of (fixed) combination therapy in case of failure of monotherapy. 9. Monitor safety. LONG-TERM CARE PLAN: 10. Uncontrolled hypertension at 6 months despite appropriate triple-drug treatment should require specialist's opinion after assessment of compliance and confirmation of ambulatory hypertension. 11. In case of controlled hypertension, visits every 3 to 6 months. 12. Track poor adherence to antihypertensive therapy. 13. Promote and teach how to practice home blood pressure measurement. 14. After 80 years, change goal BP (SBP<150 mmHg) without exceeding three antihypertensive drugs. 15. After cardiovascular complication, treatment adjustment with maintenance of same blood pressure goal. We hope that a vast dissemination of these simple guidelines will help to improve hypertension control in the French population from 50 to 70 %, an objective expected to be achieved in 2015 in France.

15 Guideline [Preventive cardiovascular recommendations]. 2012

Galán, Antonio Maiques / Cuixart, Carlos Brotons / Álvarez, Fernando Villar / Pérez, Jorge Navarro / Lobos-Bejarano, José María / Sánchez-Pinilla, Ricardo Ortega / Rioboó, Enrique Martín / Banegas Banegas, José Ramón / Orozco-Beltrán, Domingo / Guillén, Vicente Gil / Anonymous5690749. ·Grupo de Prevención Cardiovascular del PAPPS. ·Aten Primaria · Pubmed #23399503.

ABSTRACT: -- No abstract --

16 Guideline 2011 ASA/ACCF/AHA/AANN/AANS/ACR/ASNR/CNS/SAIP/SCAI/SIR/SNIS/SVM/SVS guideline on the management of patients with extracranial carotid and vertebral artery disease: executive summary. 2011

Anonymous3080707 / Anonymous3090707 / Anonymous3100707 / Anonymous3110707 / Anonymous3120707 / Anonymous3130707 / Anonymous3140707 / Anonymous3150707 / Anonymous3160707 / Anonymous3170707 / Anonymous3180707 / Anonymous3190707 / Anonymous3200707 / Anonymous3210707 / Anonymous3220707 / Brott, Thomas G / Halperin, Jonathan L / Abbara, Suhny / Bacharach, J Michael / Barr, John D / Bush, Ruth L / Cates, Christopher U / Creager, Mark A / Fowler, Susan B / Friday, Gary / Hertzberg, Vicki S / McIff, E Bruce / Moore, Wesley S / Panagos, Peter D / Riles, Thomas S / Rosenwasser, Robert H / Taylor, Allen J. ·ASA Representative. ·J Neurointerv Surg · Pubmed #21990803.

ABSTRACT: -- No abstract --

17 Guideline [The metabolic syndrome--clinical significance in 2011. Position statement of the Hungarian Diabetes Society, Metabolism Work Group]. 2011

Barkai, László / Halmos, Tamás / Hidvégi, Tibor / Jermendy, György / Korányi, László / Madácsy, László / Pados, Gyula / Winkler, Gábor / Anonymous5840703. ·Bajcsy-Zsilinszky Korhaz, Belgyogyaszati Osztaly, Budapest. ·Orv Hetil · Pubmed #21865147.

ABSTRACT: -- No abstract --

18 Guideline ACCF/AHA/AMA-PCPI 2011 performance measures for adults with coronary artery disease and hypertension: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures and the American Medical Association-Physician Consortium for Performance Improvement. 2011

Drozda, Joseph / Messer, Joseph V / Spertus, John / Abramowitz, Bruce / Alexander, Karen / Beam, Craig T / Bonow, Robert O / Burkiewicz, Jill S / Crouch, Michael / Goff, David C / Hellman, Richard / James, Thomas / King, Marjorie L / Machado, Edison A / Ortiz, Eduardo / O'Toole, Michael / Persell, Stephen D / Pines, Jesse M / Rybicki, Frank J / Sadwin, Lawrence B / Sikkema, Joanna D / Smith, Peter K / Torcson, Patrick J / Wong, John B / Anonymous17820697 / Anonymous17830697 / Anonymous17840697 / Anonymous17850697 / Anonymous17860697 / Anonymous17870697 / Anonymous17880697 / Anonymous17890697 / Anonymous17900697. ·ACCF/AHA. ·J Am Coll Cardiol · Pubmed #21676572.

ABSTRACT: -- No abstract --

19 Guideline [Hypertension and associated clinical conditions]. 2010

Ferreira Filho, Sebastião / Paula, Rogério Baumgratz de / Avezum, Alvaro / Freitas, Gabriel R de / Francischetti, Emílio / Batista, Marcelo / Carvalho, Maria Helena Catelli / Zanella, Maria Tereza / Gomes, Marília de Brito / Wajngarten, Maurício / Melo, Nilson Roberto de / Coelho, Otávio Rizzi / Meirelles, Ricardo M da Rocha / Miranda, Roberto / Milagres, Rosangela / Anonymous410716 / Anonymous420716 / Anonymous430716. ·ABN. ·J Bras Nefrol · Pubmed #22262213.

ABSTRACT: -- No abstract --

20 Guideline [Hypertension in special situations]. 2010

Poli-de-Figueiredo, Carlos E / Tavares, Agostinho / Freitas, Elizabete Viana de / Burdmann, Emmanuel de Almeida / Oliveira, Ivan Luiz Cordovil de / Magalhães, Lucélia C / Sass, Nelson / Bresolin, Nilzete Liberato / Bezerra, Romero / Koch, Vera / Fagundes, Virginia Genelhu / Anonymous380716 / Anonymous390716 / Anonymous400716. ·SBGG. ·J Bras Nefrol · Pubmed #22262212.

ABSTRACT: -- No abstract --

21 Guideline [Drug therapy]. 2010

Kohlmann, Osvaldo / Gus, Miguel / Ribeiro, Artur Beltrame / Vianna, Denizar / Coelho, Eduardo B / Barbosa, Eduardo / Almeida, Fernando Antonio / Feitosa, Gilson / Moreno, Heitor / Guimarães, Jorge Ilha / Ribeiro, Jorge Pinto / Ramirez, José Antonio Franchini / Martins, José Fernando Vilela / Santos, Robson Augusto S dos / Anonymous320716 / Anonymous330716 / Anonymous340716. ·SBC. ·J Bras Nefrol · Pubmed #22262210.

ABSTRACT: -- No abstract --

22 Guideline [Conceptualization, epidemiology, and primary prevention]. 2010

Brandão, Andréa A / Magalhães, Maria Eliane Campos / Avila, Adriana / Tavares, Agostinho / Machado, Carlos Alberto / Campana, Erika Maria Gonçalves / Lessa, Ines / Krieger, José Eduardo / Scala, Luiz Cesar / Neves, Mario Fritsch / Silva, Rita de Cássia Gengo E / Sampaio, Rosa / Anonymous170716 / Anonymous180716 / Anonymous190716. ·Ministério da Saúde. ·J Bras Nefrol · Pubmed #22262205.

ABSTRACT: -- No abstract --

23 Guideline Using bevacizumab to treat metastatic cancer: UK consensus guidelines. 2010

Miles, D / Bridgewater, J / Ellis, P / Harrison, M / Nathan, P / Nicolson, M / Raouf, S / Wheatley, D / Plummer, C. ·Mount Vernon Cancer Centre, London. ·Br J Hosp Med (Lond) · Pubmed #21135762.

ABSTRACT: Concise guidance is lacking for the use of bevacizumab by practicing oncologists. Eight oncologists with experience of bevacizumab were joined by a cardiologist interested in treating hypertension to develop practical guidelines for managing patients receiving bevacizumab, using available clinical data.

24 Editorial Renal Complications during Pregnancy: In the Hypertension Spectrum. 2019

Leikin, Jerrold B. ·Editor-in-Chief. ·Dis Mon · Pubmed #29526394.

ABSTRACT: -- No abstract --

25 Editorial Hypertension-A Public Health Challenge of Global Proportions. 2018

Fisher, Naomi D L / Curfman, Gregory. ·Brigham and Women's Hospital, Boston, Massachusetts. · Deputy Editor. ·JAMA · Pubmed #30398584.

ABSTRACT: -- No abstract --

Next